| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Prostaglandin G/H synthase 2|Cyclooxygenase-2|COX-2|PHS II|Prostaglandin H2 synthase 2|PGH synthase 2, PGHS-2|Prostaglandin-endoperoxide synthase 2|PTGS2|COX2 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human COX-2 (Cyclooxygenase-2) is a molecular target commonly studied in cancer, cardiovascular, and metabolism research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of COX-2 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of COX-2 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
COX-2 (Cyclooxygenase-2) may also be referenced as Prostaglandin G/H synthase 2, Cyclooxygenase-2, and COX-2 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how COX-2 relates to tumor microenvironment biology, cell proliferation and apoptosis, metastasis and invasion pathways, and angiogenesis and immune-oncology mechanisms in cancer, cardiovascular, and metabolism research.
- Interpreting shifts in COX-2 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
COX-2 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with cancer, cardiovascular, and metabolism studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Serum IL-1β as a Novel Predictor of No-Reflow in STEMI Patients Undergoing Primary PCI
IF: 4.1 Journal: Journal of Inflammation Research Author: Department of Cardiology, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, People's Republic of China. Cited Date: 2025-11-07
Synthesis of new imidazole-triazole-glycoside hybrids as anti-breast cancer candidates
IF: 3.841 Journal: Journal of Molecular Structure Cited Date: 2022-08-18
Anti-colorectal cancer activity of constructed oleogels based on encapsulated bioactive canola extract in lecithin for edible semisolid applications
IF: 3.8 Journal: Scientific Reports Author: Fats and Oils Department, Food Industries and Nutrition Research Institute, National Research Centre, 33 El Bohouth St., Dokki, P.O.12622, Giza, Egypt. Cited Date: 2025-02-21
A New Study on the Effect of Scopoletin and Silver Nanoparticles of Fenugreek Extract as Pancreatic Cancer Inhibition Agents: A new investigation into the effect of
IF: Journal: Academic Science Journal Author: Department of Chemistry, College of Education for Pure Science (Ibn Al-Haitham), University of Baghdad Cited Date: 2024-05-06
Melittin, A Potential Natural Toxin with Anticancer Properties: Regulating IL-1β, COX-2 and TNF-α in Human Colorectal Cancer Cells WiDr
IF: Journal: Trends in Sciences Author: Department of Nursing Pharmacology, STIKES Panakkukang, Makassar, South Sulawesi 90231, Indonesia Cited Date: 2024-03-15